Publicacións

O CITEEC lidera a investigación en enxeñaría civil e edificación, enfocándose en solucións innovadoras para infraestruturas sostibles e materiais avanzados.

Home > Publicacións

publicacións

Investigación de vangarda para o desenvolvemento sostible

O CITEEC realiza investigación avanzada en enxeñaría civil, materiais, sustentabilidade e infraestruturas. A través de proxectos multidisciplinarios e colaboracións internacionais, xéranse publicacións científicas que abordan retos crave do sector. Nesta sección preséntanse as principais publicacións e resultados obtidos polos nosos grupos de investigación.

Accede a unha ampla variedade de publicacións científicas filtradas por temática, autor, ano e máis. Utiliza os filtros dispoñibles para atopar investigacións relevantes e obter detalles sobre cada unha das nosas contribucións ao avance do coñecemento.

Investigación de vangarda para o desenvolvemento sostible

Show all

2025

Dominguez-Gortaire, Jose; Ruiz, Alejandra; Porto-Pazos, Ana Belén; Rodríguez-Yáñez, Santiago; Cedrón, Francisco

Alzheimer’s Disease: Exploring Pathophysiological Hypotheses and the Role of Machine Learning in Drug Discovery Journal Article

In: International Journal of Molecular Sciences, vol. 26, no. 3, pp. 1004, 2025, ISSN: 1422-0067.

Abstract | Links | BibTeX | Etiquetas: AI applications, machine learning, mitochondrial dysfunctions, molecular docking, neuroinflammation, pathophysiology, therapeutic target, virtual screening

@article{dominguez-gortaire_alzheimers_2025,

title = {Alzheimer’s Disease: Exploring Pathophysiological Hypotheses and the Role of Machine Learning in Drug Discovery},

author = {Jose Dominguez-Gortaire and Alejandra Ruiz and Ana Belén Porto-Pazos and Santiago Rodríguez-Yáñez and Francisco Cedrón},

url = {https://www.mdpi.com/1422-0067/26/3/1004},

doi = {10.3390/ijms26031004},

issn = {1422-0067},

year  = {2025},

date = {2025-01-01},

urldate = {2025-01-01},

journal = {International Journal of Molecular Sciences},

volume = {26},

number = {3},

pages = {1004},

publisher = {Multidisciplinary Digital Publishing Institute},

abstract = {Alzheimer’s disease (AD) is a major neurodegenerative dementia, with its complex pathophysiology challenging current treatments. Recent advancements have shifted the focus from the traditionally dominant amyloid hypothesis toward a multifactorial understanding of the disease. Emerging evidence suggests that while amyloid-beta (Aβ) accumulation is central to AD, it may not be the primary driver but rather part of a broader pathogenic process. Novel hypotheses have been proposed, including the role of tau protein abnormalities, mitochondrial dysfunction, and chronic neuroinflammation. Additionally, the gut–brain axis and epigenetic modifications have gained attention as potential contributors to AD progression. The limitations of existing therapies underscore the need for innovative strategies. This study explores the integration of machine learning (ML) in drug discovery to accelerate the identification of novel targets and drug candidates. ML offers the ability to navigate AD’s complexity, enabling rapid analysis of extensive datasets and optimizing clinical trial design. The synergy between these themes presents a promising future for more effective AD treatments.},

keywords = {AI applications, machine learning, mitochondrial dysfunctions, molecular docking, neuroinflammation, pathophysiology, therapeutic target, virtual screening},

pubstate = {published},

tppubtype = {article}

}